发达国家胃肠炎治疗：系统回顾与荟萃分析

数据集获取（Figshare）

• 源站标题：Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis
• DOI：10.1371/journal.pone.0128754
• 发布日期：2015-06-15
• 文件数：8 个
• 文件总体积：781.39 KB
• 源站页面：https://plos.figshare.com/articles/dataset/_Gastroenteritis_Therapies_in_Developed_Countries_Systematic_Review_and_Meta_Analysis_/1450034

命令行下载

curl -L -o "S1_File.pdf" "https://ndownloader.figshare.com/files/2113832"
curl -L -o "S2_File.doc" "https://ndownloader.figshare.com/files/2113833"
curl -L -o "S1_Table.doc" "https://ndownloader.figshare.com/files/2113834"
curl -L -o "S2_Table.doc" "https://ndownloader.figshare.com/files/2113835"
curl -L -o "S3_Table.doc" "https://ndownloader.figshare.com/files/2113836"
curl -L -o "S4_Table.doc" "https://ndownloader.figshare.com/files/2113837"
curl -L -o "S5_Table.doc" "https://ndownloader.figshare.com/files/2113838"
curl -L -o "S6_Table.pdf" "https://ndownloader.figshare.com/files/2113839"

文件清单

• S1_File.pdf（204.55 KB）
• S2_File.doc（36.35 KB）
• S1_Table.doc（157.70 KB）
• S2_Table.doc（90.62 KB）
• S3_Table.doc（78.34 KB）
• S4_Table.doc（67.58 KB）
• S5_Table.doc（68.61 KB）
• S6_Table.pdf（77.64 KB）

文件总体积 781.39 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Context
Gastroenteritis remains a leading cause of childhood morbidity.
Objective
Because prior reviews have focused on isolated symptoms and studies conducted in developing countries, this study focused on interventions commonly considered for use in developed countries. Intervention specific, patient-centered outcomes were selected.
Data Sources
MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, trial registries, grey literature, and scientific meetings.
Study Selection
Randomized controlled trials, conducted in developed countries, of children aged Data Extraction
The study was conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the PRISMA guidelines. Data were independently extracted by multiple investigators. Analyses employed random effects models.
Results
31 trials (4,444 patients) were included. ORT: Compared with intravenous rehydration, hospitalization (RR 0.80, 95%CI 0.24, 2.71) and emergency department return visits (RR 0.86, 95%CI 0.39, 1.89) were similar. Antiemetics: Fewer children administered an antiemetic required intravenous rehydration (RR 0.40, 95%CI 0.26, 0.60) While the data could not be meta-analyzed, three studies reported that ondansetron administration does increase the frequency of diarrhea. Probiotics: No studies reported on the primary outcome, three studies evaluated hospitalization within 7 days (RR 0.87, 95%CI 0.25, 2.98). Rehydration: No difference in length of stay was identified for rapid vs. standard intravenous or nasogastric rehydration. A single study found that 5% dextrose in normal saline reduced hospitalizations compared with normal saline alone (RR 0.70, 95% CI 0.53, 0.92).
Conclusions
There is a paucity of patient-centered outcome evidence to support many interventions. Since ORT is a low-cost, non-invasive intervention, it should continue to be used. Routine probiotic use cannot be endorsed at this time in outpatient children with gastroenteritis. Despite some evidence that ondansetron administration increases diarrhea frequency, emergency department use leads to reductions in intravenous rehydration and hospitalization. No benefits were associated with ondansetro

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0128754（source: https://plos.figshare.com/articles/dataset/_Gastroenteritis_Therapies_in_Developed_Countries_Systematic_Review_and_Meta_Analysis_/1450034）。